{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T21:49:53Z","timestamp":1787003393902,"version":"build-2736575974"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,7,29]],"date-time":"2019-07-29T00:00:00Z","timestamp":1564358400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,7,29]],"date-time":"2019-07-29T00:00:00Z","timestamp":1564358400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100005363","name":"Universidad de Buenos Aires","doi-asserted-by":"publisher","award":["UBACYT 20020130100415BA"],"award-info":[{"award-number":["UBACYT 20020130100415BA"]}],"id":[{"id":"10.13039\/501100005363","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Hyaluronan (HA) is the main glycosaminoglycan of the extracellular matrix. CD44 is the most important HA receptor, and both have been associated with poor prognosis in cancer. Chronic myeloid leukemia (CML) is characterized by the presence of a constitutively activated tyrosine kinase (Breakpoint Cluster Region - Abelson murine leukemia viral oncogene homolog1, BCR-ABL). It is mainly treated with BCR-ABL inhibitors, such as imatinib. However, the selection of resistant cells leads to treatment failure. The aim of this work was to determine the capacity of HA (high molecular weight) to counteract the effect of imatinib in human CML cell lines (K562 and Kv562). We demonstrated that imatinib decreased HA levels and the surface expression of CD44 in both cell lines. Furthermore, HA abrogated the anti-proliferative and pro-senescent effect of Imatinib without modifying the imatinib-induced apoptosis. Moreover, the inhibition of HA synthesis with 4-methylumbelliferone enhanced the anti-proliferative effect of imatinib. These results suggest that Imatinib-induced senescence would depend on the reduction in HA levels, describing, for the first time, the role of HA in the development of resistance to imatinib. These findings show that low levels of HA are crucial for an effective therapy with imatinib in CML.<\/jats:p>","DOI":"10.1038\/s41598-019-47248-8","type":"journal-article","created":{"date-parts":[[2019,7,29]],"date-time":"2019-07-29T06:21:36Z","timestamp":1564381296000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Hyaluronan abrogates imatinib-induced senescence in chronic myeloid leukemia cell lines"],"prefix":"10.1038","volume":"9","author":[{"given":"Silvina","family":"Lompard\u00eda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mari\u00e1ngeles","family":"D\u00edaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mat\u00edas","family":"Pibuel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Papademetrio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Poodts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cintia","family":"Mihalez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c9lida","family":"\u00c1lvarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Hajos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,7,29]]},"reference":[{"key":"47248_CR1","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan, D. & Weinberg, R. A. Hallmarks of cancer: The next generation. Cell 144, 646\u2013674 (2011).","journal-title":"Cell"},{"key":"47248_CR2","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1093\/glycob\/cws218","volume":"23","author":"AB Csoka","year":"2013","unstructured":"Csoka, A. B. & Stern, R. Hypotheses on the evolution of hyaluronan: A highly ironic acid. Glycobiology 23, 398\u2013411 (2013).","journal-title":"Glycobiology"},{"key":"47248_CR3","doi-asserted-by":"publisher","first-page":"4434","DOI":"10.1074\/jbc.M116.774109","volume":"292","author":"W Su","year":"2017","unstructured":"Su, W. et al. CD44 transmembrane receptor and hyaluronan regulate adult hippocampal neural stem cell quiescence and differentiation. J. Biol. Chem. 292, 4434\u20134445 (2017).","journal-title":"J. Biol. Chem."},{"key":"47248_CR4","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1152\/physrev.00052.2009","volume":"91","author":"D Jiang","year":"2011","unstructured":"Jiang, D., Liang, J. & Noble, P. W. Hyaluronan as an immune regulator in human diseases. Physiol. Rev. 91, 221\u2013264 (2011).","journal-title":"Physiol. Rev."},{"key":"47248_CR5","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.matbio.2014.01.014","volume":"35","author":"VC Hascall","year":"2014","unstructured":"Hascall, V. C. et al. The dynamic metabolism of hyaluronan regulates the cytosolic concentration of UDP-GlcNAc. Matrix Biol. 35, 14\u201317 (2014).","journal-title":"Matrix Biol."},{"key":"47248_CR6","doi-asserted-by":"publisher","first-page":"2108","DOI":"10.1096\/fj.201500178R","volume":"30","author":"V Bourguignon","year":"2016","unstructured":"Bourguignon, V. & Flamion, B. Respective roles of hyaluronidases 1 and 2 in endogenous hyaluronan turnover. FASEB J. 30, 2108\u20132114 (2016).","journal-title":"FASEB J."},{"key":"47248_CR7","doi-asserted-by":"publisher","first-page":"25419","DOI":"10.1074\/jbc.M112.376699","volume":"287","author":"V Goncharova","year":"2012","unstructured":"Goncharova, V. et al. Hyaluronan expressed by the hematopoietic microenvironment is required for bone marrow hematopoiesis. J. Biol. Chem. 287, 25419\u201325433 (2012).","journal-title":"J. Biol. Chem."},{"key":"47248_CR8","doi-asserted-by":"crossref","unstructured":"Khaldoyanidi, S. K., Goncharova, V., Mueller, B. & Schraufstatter, I. U. Hyaluronan in the healthy and malignant hematopoietic microenvironment. Advances in cancer research 123 (2014).","DOI":"10.1016\/B978-0-12-800092-2.00006-X"},{"key":"47248_CR9","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.yexcr.2010.11.017","volume":"317","author":"RK Sironen","year":"2011","unstructured":"Sironen, R. K. et al. Hyaluronan in human malignancies. Experimental Cell Research 317, 383\u2013391 (2011).","journal-title":"Experimental Cell Research"},{"key":"47248_CR10","doi-asserted-by":"publisher","first-page":"7462","DOI":"10.1158\/1078-0432.CCR-09-0479","volume":"15","author":"BP Toole","year":"2009","unstructured":"Toole, B. P. Hyaluronan-CD44 Interactions in Cancer: Paradoxes and Possibilities. Clin. Cancer Res. 15, 7462\u20137468 (2009).","journal-title":"Clin. Cancer Res."},{"key":"47248_CR11","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1038\/nrc1391","volume":"4","author":"BP Toole","year":"2004","unstructured":"Toole, B. P. Hyaluronan: from extracellular glue to pericellular cue. Nat. Rev. Cancer 4, 528\u2013539 (2004).","journal-title":"Nat. Rev. Cancer"},{"key":"47248_CR12","doi-asserted-by":"publisher","unstructured":"Tammi, M. I. et al. Activated hyaluronan metabolism in the tumor matrix \u2014 Causes and consequences. Matrix Biology, https:\/\/doi.org\/10.1016\/j.matbio.2018.04.012 (2018).","DOI":"10.1016\/j.matbio.2018.04.012"},{"key":"47248_CR13","doi-asserted-by":"publisher","unstructured":"Heldin, P., Lin, C. Y., Kolliopoulos, C., Chen, Y. H. & Skandalis, S. S. Regulation of hyaluronan biosynthesis and clinical impact of excessive hyaluronan production. Matrix Biology, https:\/\/doi.org\/10.1016\/j.matbio.2018.01.017 (2018).","DOI":"10.1016\/j.matbio.2018.01.017"},{"key":"47248_CR14","doi-asserted-by":"crossref","unstructured":"Karousou, E. et al. Roles and targeting of the HAS\/hyaluronan\/CD44 molecular system in cancer. Matrix Biology 59 (2017).","DOI":"10.1016\/j.matbio.2016.10.001"},{"key":"47248_CR15","first-page":"114","volume":"107","author":"N von Bubnoff","year":"2010","unstructured":"von Bubnoff, N. & Duyster, J. Chronic Myelogenous Leukemia. Dtsch. Arztebl. Int. 107, 114\u2013121 (2010).","journal-title":"Dtsch. Arztebl. Int."},{"key":"47248_CR16","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/1756-8722-3-47","volume":"3","author":"G Wei","year":"2010","unstructured":"Wei, G., Rafiyath, S. & Liu, D. First-line treatment for chronic myeloid leukemia: dasatinib, nilotinib, or imatinib. J. Hematol. Oncol. 3, 47 (2010).","journal-title":"J. Hematol. Oncol."},{"key":"47248_CR17","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.cancergen.2011.03.002","volume":"204","author":"HS Chandraa","year":"2011","unstructured":"Chandraa, H. S. et al. Philadelphia Chromosome Symposium: commemoration of the 50th anniversary of the discovery of the Ph chromosome. Cancer Genet. 204, 171\u2013179 (2011).","journal-title":"Cancer Genet."},{"key":"47248_CR18","doi-asserted-by":"publisher","unstructured":"Zhou, H. et al. Combined inhibition of \u03b2-catenin and Bcr\u2013Abl synergistically targets tyrosine kinase inhibitor-resistant blast crisis chronic myeloid leukemia blasts and progenitors in vitro and in vivo. Leukemia, https:\/\/doi.org\/10.1038\/leu.2017.87 (2017).","DOI":"10.1038\/leu.2017.87"},{"key":"47248_CR19","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1093\/glycob\/cwt074","volume":"23","author":"SL Lompard\u00eda","year":"2013","unstructured":"Lompard\u00eda, S. L., Papademetrio, D. L., Mascar\u00f3, M., Del Carmen \u00c1lvarez, E. M. & Hajos, S. E. Human leukemic cell lines synthesize hyaluronan to avoid senescence and resist chemotherapy. Glycobiology 23, 1463\u20131476 (2013).","journal-title":"Glycobiology"},{"key":"47248_CR20","doi-asserted-by":"publisher","unstructured":"Lompard\u00eda, S. L. et al. 4-methylumbelliferone and imatinib combination enhances senescence induction in chronic myeloid leukemia cell lines. Investigational New Drugs 1\u201310, https:\/\/doi.org\/10.1007\/s10637-016-0397-9 (2017).","DOI":"10.1007\/s10637-016-0397-9"},{"key":"47248_CR21","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1093\/glycob\/cwv107","volume":"26","author":"SL Lompard\u00eda","year":"2016","unstructured":"Lompard\u00eda, S. L. et al. Hyaluronan oligomers sensitize chronic myeloid leukemia cell lines to the effect of Imatinib. Glycobiology 26, 343\u2013352 (2016).","journal-title":"Glycobiology"},{"key":"47248_CR22","doi-asserted-by":"publisher","first-page":"1914","DOI":"10.1016\/j.yexcr.2009.03.002","volume":"315","author":"A Kultti","year":"2009","unstructured":"Kultti, A. et al. 4-Methylumbelliferone inhibits hyaluronan synthesis by depletion of cellular UDP-glucuronic acid and downregulation of hyaluronan synthase 2 and 3. Exp. Cell Res. 315, 1914\u20131923 (2009).","journal-title":"Exp. Cell Res."},{"key":"47248_CR23","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.exphem.2013.11.006","volume":"42","author":"EG Karimiani","year":"2014","unstructured":"Karimiani, E. G. et al. Single-cell analysis of K562 cells: An imatinib-resistant subpopulation is adherent and has upregulated expression of BCR-ABL mRNA and protein. Exp. Hematol. 42, 183\u2013191 (2014).","journal-title":"Exp. Hematol."},{"key":"47248_CR24","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.jim.2005.07.012","volume":"305","author":"R Wetzel","year":"2005","unstructured":"Wetzel, R. et al. Evaluation of CML model cell lines and imatinib mesylate response: Determinants of signaling profiles. in. Journal of Immunological Methods 305, 59\u201366 (2005).","journal-title":"Journal of Immunological Methods"},{"key":"47248_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2012.111","volume":"3","author":"C Drullion","year":"2012","unstructured":"Drullion, C. et al. Apoptosis and autophagy have opposite roles on imatinib-induced K562 leukemia cell senescence. Cell Death Dis. 3, e373 (2012).","journal-title":"Cell Death Dis."},{"key":"47248_CR26","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1038\/cdd.2011.96","volume":"19","author":"L Galluzzi","year":"2012","unstructured":"Galluzzi, L. et al. Molecular definitions of cell death subroutines: recommendations of the Nomenclature Committee on Cell Death 2012. Cell Death Differ. 19, 107\u2013120 (2012).","journal-title":"Cell Death Differ."},{"key":"47248_CR27","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1083\/jcb.201009094","volume":"192","author":"F Rodier","year":"2011","unstructured":"Rodier, F. & Campisi, J. Four faces of cellular senescence. J. Cell Biol. 192, 547\u2013556 (2011).","journal-title":"J. Cell Biol."},{"key":"47248_CR28","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1146\/annurev-physiol-030212-183653","volume":"75","author":"J Campisi","year":"2013","unstructured":"Campisi, J. Aging, cellular senescence, and cancer. Annu. Rev. Physiol. 75, 685\u2013705 (2013).","journal-title":"Annu. Rev. Physiol."},{"key":"47248_CR29","doi-asserted-by":"crossref","unstructured":"Childs, B. G., Baker, D. J., Kirkland, J. L., Campisi, J. & van Deursen, J. M. Senescence and apoptosis: dueling or complementary cell fates? EMBO Rep. 15 (2014).","DOI":"10.15252\/embr.201439245"},{"key":"47248_CR30","doi-asserted-by":"crossref","unstructured":"He, S. & Sharpless, N. E. Senescence in Health and Disease. Cell 169 (2017).","DOI":"10.1016\/j.cell.2017.05.015"},{"key":"47248_CR31","doi-asserted-by":"crossref","unstructured":"Gewirtz, D. A. A and Senescence in Cancer Therapy. J. Cell. Physiol. 229 (2014).","DOI":"10.1002\/jcp.24420"},{"key":"47248_CR32","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1620\/tjem.220.229","volume":"220","author":"T Yasuda","year":"2010","unstructured":"Yasuda, T. Hyaluronan Inhibits Prostaglandin E2 Production via CD44 in U937 Human Macrophages. Tohoku J. Exp. Med. 220, 229\u2013235 (2010).","journal-title":"Tohoku J. Exp. Med."},{"key":"47248_CR33","doi-asserted-by":"publisher","first-page":"24639","DOI":"10.1074\/jbc.M110.134536","volume":"285","author":"D Vigetti","year":"2010","unstructured":"Vigetti, D. et al. Proinflammatory Cytokines Induce Hyaluronan Synthesis and Monocyte Adhesion in Human Endothelial Cells through Hyaluronan Synthase 2 (HAS2) and the Nuclear Factor- B (NF- B) Pathway. J. Biol. Chem. 285, 24639\u201324645 (2010).","journal-title":"J. Biol. Chem."},{"key":"47248_CR34","doi-asserted-by":"publisher","first-page":"2337","DOI":"10.1007\/s00018-015-1867-5","volume":"72","author":"J Bertacchini","year":"2015","unstructured":"Bertacchini, J. et al. Targeting PI3K\/AKT\/mTOR network for treatment of leukemia. Cellular and Molecular Life Sciences 72, 2337\u20132347 (2015).","journal-title":"Cellular and Molecular Life Sciences"},{"key":"47248_CR35","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1111\/ejh.12743","volume":"97","author":"N Gunnarsson","year":"2016","unstructured":"Gunnarsson, N. et al. Population-based assessment of chronic myeloid leukemia in Sweden: striking increase in survival and prevalence. Eur. J. Haematol. 97, 387\u2013392 (2016).","journal-title":"Eur. J. Haematol."},{"key":"47248_CR36","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/s13045-018-0624-2","volume":"11","author":"F Rossari","year":"2018","unstructured":"Rossari, F., Minutolo, F. & Orciuolo, E. Past, present, and future of Bcr-Abl inhibitors: from chemical development to clinical efficacy. J Hematol Oncol. 11, 84 (2018).","journal-title":"J Hematol Oncol."},{"key":"47248_CR37","doi-asserted-by":"crossref","unstructured":"Zanforlin, E., Zagotto, G. & Ribaudo, G. A Chemical Approach to Overcome Tyrosine Kinase Inhibitors Resistance: Learning from Chronic Myeloid Leukemia. Curr. Med. Chem. Epub ahead (2018).","DOI":"10.2174\/0929867325666180607092451"},{"key":"47248_CR38","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1016\/j.leukres.2013.07.019","volume":"37","author":"T Shibuta","year":"2013","unstructured":"Shibuta, T. et al. Imatinib induces demethylation of miR-203 gene: An epigenetic mechanism of anti-tumor effect of imatinib. Leuk. Res. 37, 1278\u20131286 (2013).","journal-title":"Leuk. Res."},{"key":"47248_CR39","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/onc.2012.557","volume":"33","author":"C Xu","year":"2014","unstructured":"Xu, C. et al. BCR-ABL\/GATA1\/miR-138 mini circuitry contributes to the leukemogenesis of chronic myeloid leukemia. Oncogene 33, 44\u201354 (2014).","journal-title":"Oncogene"},{"key":"47248_CR40","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/S0945-053X(01)00172-X","volume":"20","author":"AB Csoka","year":"2001","unstructured":"Csoka, A. B., Frost, G. I. & Stern, R. The six hyaluronidase-like genes in the human and mouse genomes. Matrix Biology 20, 499\u2013508 (2001).","journal-title":"Matrix Biology"},{"key":"47248_CR41","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1093\/rheumatology\/ken431","volume":"48","author":"JHW Distler","year":"2009","unstructured":"Distler, J. H. W. & Distler, O. Imatinib as a novel therapeutic approach for fibrotic disorders. Rheumatology 48, 2\u20134 (2009).","journal-title":"Rheumatology"},{"key":"47248_CR42","doi-asserted-by":"publisher","first-page":"2477","DOI":"10.1111\/febs.12163","volume":"280","author":"CJ Malavaki","year":"2013","unstructured":"Malavaki, C. J. et al. Imatinib as a key inhibitor of the platelet-derived growth factor receptor mediated expression of cell surface heparan sulfate proteoglycans and functional properties of breast cancer cells. FEBS J. 280, 2477\u20132489 (2013).","journal-title":"FEBS J."},{"key":"47248_CR43","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1158\/1541-7786.MCR-07-0355","volume":"6","author":"V Gioni","year":"2008","unstructured":"Gioni, V. et al. Imatinib Mesylate Inhibits Proliferation and Exerts an Antifibrotic Effect in Human Breast Stroma Fibroblasts. Mol. Cancer Res. 6, 706\u2013714 (2008).","journal-title":"Mol. Cancer Res."},{"key":"47248_CR44","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1136\/bjo.2010.192302","volume":"95","author":"L van Steensel","year":"2011","unstructured":"van Steensel, L. et al. Whole orbital tissue culture identifies imatinib mesylate and adalimumab as potential therapeutics for Graves\u2019 ophthalmopathy. Br. J. Ophthalmol. 95, 735\u2013738 (2011).","journal-title":"Br. J. Ophthalmol."},{"key":"47248_CR45","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1002\/j.1460-2075.1987.tb02356.x","volume":"6","author":"R Alitalo","year":"1987","unstructured":"Alitalo, R. et al. Induction of platelet-derived growth factor gene expression during megakaryoblastic and monocytic differentiation of human leukemia cell lines. EMBO J 6, 1213\u20131218 (1987).","journal-title":"EMBO J"},{"key":"47248_CR46","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1007\/s00018-015-2108-7","volume":"73","author":"Y Hu","year":"2016","unstructured":"Hu, Y. & Li, S. Survival regulation of leukemia stem cells. Cell. Mol. Life Sci. 73, 1039\u20131050 (2016).","journal-title":"Cell. Mol. Life Sci."},{"key":"47248_CR47","doi-asserted-by":"publisher","first-page":"84","DOI":"10.3109\/00313020903434686","volume":"42","author":"FS Hong","year":"2010","unstructured":"Hong, F. S., Mitchell, C. A. & Zantomio, D. Gelatinous transformation of the bone marrow as a late morphological change in imatinib mesylate treated chronic myeloid leukaemia. Pathology 42, 84\u20135 (2010).","journal-title":"Pathology"},{"key":"47248_CR48","doi-asserted-by":"publisher","unstructured":"Burchert, A. et al. Compensatory PI3-kinase\/Akt\/mTor activation regulates im\u2019atinib resistance development. Leukemia, https:\/\/doi.org\/10.1038\/sj.leu.2403898 (2005).","DOI":"10.1038\/sj.leu.2403898"},{"key":"47248_CR49","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1111\/j.1349-7006.2009.01365.x","volume":"101","author":"T Nambu","year":"2010","unstructured":"Nambu, T. et al. Contribution of BCR-ABL-independent activation of ERK1\/2 to acquired imatinib resistance in K562 chronic myeloid leukemia cells. Cancer Sci. 101, 137\u2013142 (2010).","journal-title":"Cancer Sci."},{"key":"47248_CR50","unstructured":"Yu, C. et al. Pharmacologic mitogen-activated protein\/extracellular signal-regulated kinase kinase\/mitogen-activated protein kinase inhibitors interact synergistically with STI571 to induce apoptosis in Bcr\/Abl-expressing human leukemia cells. Cancer Res. (2002)."},{"key":"47248_CR51","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1007\/s00018-017-2725-4","volume":"75","author":"M Goulard","year":"2018","unstructured":"Goulard, M., Dosquet, C. & Bonnet, D. Role of the microenvironment in myeloid malignancies. Cellular and Molecular Life Sciences 75, 1377\u20131391 (2018).","journal-title":"Cellular and Molecular Life Sciences"},{"key":"47248_CR52","doi-asserted-by":"publisher","first-page":"202","DOI":"10.4149\/neo_2009_03_202","volume":"56","author":"K Czyzewski","year":"2009","unstructured":"Czyzewski, K. & Styczynski, J. Imatinib is a substrate for various multidrug resistance proteins. Neoplasma 56, 202\u2013207 (2009).","journal-title":"Neoplasma"},{"key":"47248_CR53","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1016\/j.imbio.2011.12.006","volume":"217","author":"RI Cordo Russo","year":"2012","unstructured":"Cordo Russo, R. I. et al. Increased hyaluronan levels and decreased dendritic cell activation are associated with tumor invasion in murine lymphoma cell lines. Immunobiology 217, 842\u2013850 (2012).","journal-title":"Immunobiology"},{"key":"47248_CR54","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/s11523-013-0278-5","volume":"9","author":"DL Papademetrio","year":"2014","unstructured":"Papademetrio, D. L. et al. Interplay between autophagy and apoptosis in pancreatic tumors in response to gemcitabine. Target. Oncol. 9, 123\u2013134 (2014).","journal-title":"Target. Oncol."},{"key":"47248_CR55","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1593\/tlo.08202","volume":"2","author":"V Cavaliere","year":"2009","unstructured":"Cavaliere, V. et al. Caffeic acid phenylethyl ester and MG-132 have apoptotic and antiproliferative effects on leukemic cells but not on normal mononuclear cells. Transl. Oncol. 2, 46\u201358 (2009).","journal-title":"Transl. Oncol."},{"key":"47248_CR56","doi-asserted-by":"publisher","first-page":"1798","DOI":"10.1038\/nprot.2009.191","volume":"4","author":"F Debacq-Chainiaux","year":"2009","unstructured":"Debacq-Chainiaux, F., Erusalimsky, J. D., Campisi, J. & Toussaint, O. Protocols to detect senescence-associated beta-galactosidase (SA-betagal) activity, a biomarker of senescent cells in culture and in vivo. Nat. Protoc. 4, 1798\u20131806 (2009).","journal-title":"Nat. Protoc."},{"key":"47248_CR57","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/s11523-015-0388-3","volume":"11","author":"DL Papademetrio","year":"2016","unstructured":"Papademetrio, D. L. et al. Inhibition of Survival Pathways MAPK and NF-kB Triggers Apoptosis in Pancreatic Ductal Adenocarcinoma Cells via Suppression of Autophagy. Target. Oncol. 11, 183\u2013195 (2016).","journal-title":"Target. Oncol."},{"key":"47248_CR58","doi-asserted-by":"publisher","unstructured":"Foucquier, J. & Guedj, M. Analysis of drug combinations: current methodological landscape. Pharmacology Research and Perspectives, https:\/\/doi.org\/10.1002\/prp2.149 (2015).","DOI":"10.1002\/prp2.149"}],"updated-by":[{"DOI":"10.1038\/s41598-020-69087-8","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2020,7,16]],"date-time":"2020-07-16T00:00:00Z","timestamp":1594857600000}}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-47248-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-47248-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-47248-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T07:02:37Z","timestamp":1671260557000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-47248-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,29]]},"references-count":58,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["47248"],"URL":"https:\/\/doi.org\/10.1038\/s41598-019-47248-8","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,29]]},"assertion":[{"value":"11 February 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 July 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2020","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"An amendment to this paper has been published and can be accessed via a link at the top of the paper.","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"10930"}}